Expert Perspective on Treating Hepatitis B Now and in the Future

This video capture of a plenary presentation from the 2019 CCO Hepatitis Annual Meeting reviews the HBV life cycle, discusses current strategies for managing chronic hepatitis B, and highlights emerging data on novel therapeutics that may soon affect practice.
Ira M. Jacobson, MD
Program Director
Paul Y. Kwo, MD
Released: June 27, 2019 Expiration: No longer available for credit

Related Content

Download free expert-authored slides on the clinical interplay of HCV and COVID-19 coinfection and the impact of the COVID-19 pandemic on access to HCV care and treatment

Ricardo Franco, MD Stacey Trooskin, MD, PhD Released: October 7, 2020

Dr. Stefan Zeuzem discusses new viral hepatitis data reported at the 2020 Digital International Liver Congress, in the CCO Infectious Disease podcast

Stefan Zeuzem, MD Released: September 14, 2020

Expert selections of the most important viral hepatitis data from EASL 2020, including HCV elimination and HCV and HBV treatment, provided by CCO

Stefan Zeuzem, MD Released: September 8, 2020

CCO commentary from Anna Christina L. dela Cruz, MD, on the use of quantitative HBsAg and elastography in the management of hepatitis B

Anna Christina L. dela Cruz, MD Released: August 18, 2020
Provided by the Annenberg Center for Health Sciences at Eisenhower
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Melissa Velasquez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Supported by educational grants from
AbbVie
Gilead Sciences
Janssen Therapeutics
Merck & Co., Inc.
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue